BLCO may be sold in 2025 to service the debt of majority shareholder BHC, and any sale will be at a premium to the current ...

This week, the European Commission granted approval to Merck’s MRK novel HIF-2α inhibitor, Welireg, for two indications. The ...

With the robust demand for personalized medicines and the growing adoption of digital technology, the precision medicine ...

Gerdau S/A Ord-3.23% R$32.89B ...

AT&T Inc. Dep. Pfd. (Rep. 1/1000th 4.75% Pfd. Series C)-0.26% AT&T Inc. Dep. Pfd. (Rep. 1/1000th 5% Perp. Pfd. Series A) 0.19% ...